MCID: DSS010
MIFTS: 38

Dissociative Disorder

Categories: Mental diseases

Aliases & Classifications for Dissociative Disorder

MalaCards integrated aliases for Dissociative Disorder:

Name: Dissociative Disorder 12 15 71
Dissociative Disorders 43
Dissociative Reaction 12
Dissociative Disease 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10935
ICD9CM 34 300.15 300.9
MeSH 43 D004213
NCIt 49 C92197
SNOMED-CT 67 44376007
ICD10 32 F44 F44.9 F48.9
UMLS 71 C0012746 C0041857

Summaries for Dissociative Disorder

Disease Ontology : 12 A disease of mental health in which the normally well-integrated functions of memory, identity, perception, or consciousness are separated (dissociated).

MalaCards based summary : Dissociative Disorder, also known as dissociative disorders, is related to dissociative amnesia and depersonalization disorder. An important gene associated with Dissociative Disorder is TNFSF11 (TNF Superfamily Member 11), and among its related pathways/superpathways is Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics. The drugs Sertraline and Rasagiline have been mentioned in the context of this disorder. Affiliated tissues include eye, endothelial and brain, and related phenotype is behavior/neurological.

Wikipedia : 74 Dissociative disorders (DD) are conditions that involve disruptions or breakdowns of memory, awareness,... more...

Related Diseases for Dissociative Disorder

Diseases related to Dissociative Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 118)
# Related Disease Score Top Affiliating Genes
1 dissociative amnesia 33.1 TNFSF11 H2AP
2 depersonalization disorder 31.7 TNFSF11 NPPA HTR2A DMTN
3 multiple personality disorder 31.2 TNFSF11 SCLY OGN NPPA IRGC DPM1
4 factitious disorder 30.0 IRGC ANKRD54
5 personality disorder 29.9 SLC6A4 HTR2A FKBP5
6 acute stress disorder 29.8 SLC6A4 OGN FKBP5
7 borderline personality disorder 29.6 SLC6A4 HTR2A FKBP5
8 somatization disorder 29.4 SLC6A4 SCLY OXT HTR2A
9 post-traumatic stress disorder 29.3 SLC6A4 HTR2A FKBP5
10 atypical depressive disorder 29.0 SLC6A4 HTR2A
11 substance abuse 29.0 SLC6A4 OGN HTR2A
12 neurotic disorder 29.0 SLC6A4 HTR2A FLNA
13 agoraphobia 28.9 SLC6A4 SCLY HTR2A
14 sexual disorder 28.9 SLC6A4 OXT HTR2A
15 alcohol use disorder 28.9 SLC6A4 HTR2A GRIN2B
16 psychotic disorder 28.8 SLC6A4 OXT HTR2A GRIN2B
17 anorexia nervosa 28.6 SLC6A4 OXT HTR2A
18 migraine with or without aura 1 28.6 SLC6A4 OXT HTR2A GRIN2B
19 endogenous depression 28.6 SLC6A4 SCLY OXT HTR2A
20 anxiety 28.4 SLC6A4 OXT HTR2A GRIN2B FKBP5
21 obsessive-compulsive disorder 28.2 SLC6A4 OXT HTR2A GRIN2B FKBP5
22 mental depression 28.0 SLC6A4 SCLY OXT HTR2A GRIN2B FKBP5
23 major depressive disorder 28.0 SLC6A4 OXT HTR2A GRIN2B FKBP5
24 attention deficit-hyperactivity disorder 28.0 SLC6A4 OXT HTR2A GRIN2B FKBP5
25 conversion disorder 12.0
26 dissociative seizures 11.5
27 amnestic disorder 10.4
28 idiopathic hypercalciuria 10.4 TNFSF11 NPPA
29 severe combined immunodeficiency 10.3
30 inappropriate adh syndrome 10.3 OXT NPPA
31 avoidant personality disorder 10.2
32 neurotic excoriation 10.1 FLNA ANKRD54
33 breast abscess 10.1 OXT FLNA
34 late congenital syphilis 10.0 OXT FLNA
35 depression 10.0
36 retrograde amnesia 10.0 SLC6A4 GRIN2B
37 postpartum depression 10.0 SLC6A4 SCLY OXT
38 asphyxia neonatorum 9.9 OXT FLNA
39 triiodothyronine receptor auxiliary protein 9.9
40 hypoactive sexual desire disorder 9.9 OXT HTR2A
41 vaginal discharge 9.9 OXT FLNA
42 major affective disorder 8 9.9
43 major affective disorder 9 9.9
44 visual epilepsy 9.9
45 bipolar disorder 9.9
46 panic disorder 9.9
47 eating disorder 9.9
48 seizure disorder 9.9
49 inhibited male orgasm 9.8 SLC6A4 OXT OGN
50 premature ejaculation 9.8 SLC6A4 OXT

Graphical network of the top 20 diseases related to Dissociative Disorder:



Diseases related to Dissociative Disorder

Symptoms & Phenotypes for Dissociative Disorder

MGI Mouse Phenotypes related to Dissociative Disorder:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.32 DPM1 FKBP5 FLNA GRIN2B HTR2A OXT

Drugs & Therapeutics for Dissociative Disorder

Drugs for Dissociative Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 107)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sertraline Approved Phase 4 79617-96-2 68617
2
Rasagiline Approved Phase 4 136236-51-6 3052776
3 Serotonin Uptake Inhibitors Phase 4
4 Serotonin Agents Phase 4
5 Antidepressive Agents Phase 4
6 Protective Agents Phase 4
7 Monoamine Oxidase Inhibitors Phase 4
8 Neuroprotective Agents Phase 4
9
Serotonin Investigational, Nutraceutical Phase 4 50-67-9 5202
10
Bevacizumab Approved, Investigational Phase 3 216974-75-3
11
Povidone Approved Phase 3 9003-39-8
12
Iodine Approved, Investigational Phase 3 7553-56-2 807
13
Lidocaine Approved, Vet_approved Phase 3 137-58-6 3676
14
Povidone-iodine Approved Phase 3 25655-41-8
15
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
16
Fluorouracil Approved Phase 3 51-21-8 3385
17
Dalteparin Approved Phase 3 9005-49-6
18
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
19 Antineoplastic Agents, Immunological Phase 3
20 cadexomer iodine Phase 3
21 Pharmaceutical Solutions Phase 3
22 Fibrinolytic Agents Phase 3
23 Anticoagulants Phase 3
24 Heparin, Low-Molecular-Weight Phase 3
25 Antimetabolites Phase 3
26 Calcium, Dietary Phase 3
27 calcium heparin Phase 3
28
Naltrexone Approved, Investigational, Vet_approved Phase 2 16590-41-3 5360515
29
Ethanol Approved Phase 2 64-17-5 702
30 Narcotics Phase 2
31 Narcotic Antagonists Phase 2
32
Ursodeoxycholic acid Approved, Investigational Phase 1 128-13-2 31401
33
Dexamethasone Approved, Investigational, Vet_approved Phase 1 50-02-2 5743
34
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 1 1177-87-3
35
Glycolic acid Approved, Investigational Phase 1 79-14-1 757
36 Endothelial Growth Factors Phase 1
37 Cholagogues and Choleretics Phase 1
38 Autonomic Agents Phase 1
39 Antiemetics Phase 1
40 Gastrointestinal Agents Phase 1
41 HIV Protease Inhibitors Phase 1
42
protease inhibitors Phase 1
43 BB 1101 Phase 1
44 Antineoplastic Agents, Hormonal Phase 1
45
Citalopram Approved 59729-33-8 2771
46
Dopamine Approved 51-61-6, 62-31-7 681
47
Aripiprazole Approved, Investigational 129722-12-9 60795
48
Olanzapine Approved, Investigational 132539-06-1 4585
49
Risperidone Approved, Investigational 106266-06-2 5073
50
Ciprofloxacin Approved, Investigational 85721-33-1 2764

Interventional clinical trials:

(show top 50) (show all 113)
# Name Status NCT ID Phase Drugs
1 On-label tReatment With Intravitreal Aflibercept Injection for Patients With Persistent Pigment Epithelial Detachments in Neovascular AMD. Unknown status NCT01670162 Phase 4 Aflibercept
2 Open Label Study: Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment. Completed NCT01722656 Phase 4 Aflibercept
3 Intravitreal Ranibizumab in Patients With Retinal Pigment Epithelial Detachments Secondary to Age-related Macular Degeneration Completed NCT00976222 Phase 4 intravitreal injection with ranibizumab
4 A 12-month, Exploratory Open-label Study of Eylea (Aflibercept) in Subjects With Retinal Pigment Epithelial Detachment Secondary to Neovascular Age-related Macular Degeneration Completed NCT02142296 Phase 4 Eylea
5 Treatment for Psychogenic Nonepileptic Seizures: A Pilot, 12 Week, Prospective, Randomized, Placebo-controlled, Double-blind, Clinical Trial of Sertraline in the Treatment of Comorbid Psychiatric Disorders in NES Completed NCT00159965 Phase 4 sertraline;placebo
6 Medication and Psychotherapy Treatment Trial for Psychogenic Nonepileptic Seizures Completed NCT00835627 Phase 4 sertraline
7 Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment Terminated NCT02068625 Phase 4 Rasagiline;Placebo
8 Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy. Withdrawn NCT01666236 Phase 4
9 Pressurized Perfluorocarbon Perfused 23 GA Vitrectomy in Complicated Diabetic Retinal Detachment Unknown status NCT00404209 Phase 3
10 Surgical Management of Pseudophakic and Aphakic Retinal Detachment; a Randomized Clinical Trial Unknown status NCT00370279 Phase 3
11 Comparison of Two High-Density Silicone Oils in Complicated Rhegmatogenous Retinal Detachment Unknown status NCT00403702 Phase 2, Phase 3 Oxane HD [oil-RMN3-mixture];Densiron [(F6H8)
12 Determining Optimal Treatment Algorithms for Macular Degeneration Pigment Epithelial Detachments Treated With Intraocular Lucentis Completed NCT00590694 Phase 2, Phase 3 ranibizumab
13 Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy: Results of the Pan-American Collaborative Retina Study (PACORES) Group Completed NCT01976923 Phase 3 Intravitreal bevacizumab
14 Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment. Recruiting NCT02834559 Phase 3 5-fluorouracil and low molecular weight heparin;Placebo
15 Patients With Conversion Gait Disorder - Effect on Treatment and Common Gait Patterns. Randomized Clinical Trial Unknown status NCT01422278 Phase 1, Phase 2
16 An Open-label Assessment of Intravitreous Injections of Vitrase (Hyaluronidase for Injection) for Inducing Posterior Vitreous Detachment in Subjects With Moderate to Severe Non-proliferative Diabetic Retinopathy Completed NCT00198471 Phase 2 Vitrase
17 Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV for Diabetic Tractional Retinal Detachment (IBETRA Study) Completed NCT00690768 Phase 2 Bevacizumab
18 The Effect of Intravitreous Ranibizumab on Intra-Operative Bleeding During Pars Plana Vitrectomy for Diabetic Traction Retinal Detachment Completed NCT01201161 Phase 2 Ranibizumab
19 Delving Intervention and Mindbody Integration Completed NCT00097305 Phase 2
20 Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder Completed NCT01133301 Phase 2 Naltrexone;Placebo
21 Intravitreal Lucentis (iL) (Ranibizumab) for the Treatment of AMD Related Pigment Epithelial Detachment (PED) Completed NCT00841581 Phase 2 Ranibizumab
22 Posterior Vitreous Detachment (PVD) Assessment During Dual RVO Lucentis Evaluations (PADDLE Study) Completed NCT00831350 Phase 2 Ranibizumab
23 Head Positioning Duration After Retinal Detachment Repair With Vitrectomy and Gas Recruiting NCT03714503 Phase 2
24 Bevacizumab Against Recurrent Retinal Detachment Active, not recruiting NCT02192970 Phase 2 Bevacizumab
25 A Randomized, Double-Masked, Placebo Controlled, Parallel Group, Multi-Center, Dose-Ranging Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Rhegmatogenous Retinal Detachment Terminated NCT00083967 Phase 2 denufosol tetrasodium (INS37217) Intravitreal Injection
26 High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study Terminated NCT01189019 Phase 2 ranibizumab;ranibizumab
27 The Multi-center Exploratory Clinical Trials for the Evaluation of Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment Unknown status NCT01261533 Phase 1
28 A Double-Masked, Randomized, Dose-Ranging Study of a Single Intravitreal (IVT) Injection of INS37217 Intravitreal Injection in Subjects With Retinal Detachment Completed NCT00210067 Phase 1 denufosol tetrasodium (INS37217) Intravitreal Injection
29 A Phase I Study to Evaluate the Efficacy and Safety of Treating Subfoveal Pigment Epithelial Detachment Associated With Choroidal Neovascularization With Anti-vascular Endothelial Growth Factor Fragment, Ranibizumab. Completed NCT00749021 Phase 1 Ranibizumab;Ranibizumab;Ranibizumab;Ranibizumab
30 Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment Completed NCT00548197 Phase 1 Bevacizumab
31 Ursodeoxycholic Acid (UDCA) as Adjuvant Treatment for Rhegmatogenous Retinal Detachment: a Phase I Pilot Study Completed NCT02841306 Phase 1 Ursodeoxycholic Acid
32 Dexamethasone Intravitreal Implant for the Management of Exudative Retinal Detachment in Patients With Uveal Melanoma Recruiting NCT04082962 Phase 1 Dexamethasone intravitreal implant
33 A Phase 1 Open-Label, Dose Escalation Study to Assess the Safety and Tolerability of Intravitreal ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment Recruiting NCT03780972 Phase 1 ONL1204
34 VidRT: Video Distraction During Radiation Therapy to Decrease Use of Pediatric Sedation Recruiting NCT03677531 Phase 1
35 A Psychopathological Study of Dissociative Disorders in Psychiatric Inpatients at an Acute Stage Unknown status NCT01388140
36 The Interest of a Specific Combined Treatment (Psychotherapy and Pharmacotherapy) in Patients With Dissociative Disorders Unknown status NCT00630981 Pharmacological treatment (Quetiapine and/or Escitalopram)
37 Cognitive Behavioural Therapy in Dissociative Seizures: A Randomised Controlled Trial Unknown status NCT00688727
38 Intravitreous CytokinE Level in pAtient With retiNal Detachment Unknown status NCT03318588
39 A Pilot, Single-center, Interventional Clinical Trial in Which Subjects With Vascularized Pigment Epithelial Detachment (V-PED) Secondary to AMD With Serous Component Superior to 50% of the Lesion Will Receive Low Voltage Stereotactic Radiotherapy (IRay®) Treatment and Lucentis Treatment as Needed. Unknown status NCT01521819 Lucentis
40 The Explore Study for the Efficacy and Safety of Multi-electrocoagulation Retinectomy in the Treatment of Retinal Re-detachment in Silicone Oil Filled Eye Unknown status NCT02201706
41 Corneal Endothelial Cell Loss After Pneumatic Retinopexy for the Repair of Primary Rhegmatogenous Retinal Detachment Unknown status NCT02185469 sulfur hexafluoride (SF6)
42 Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery: Randomised Clinical Trial of Safety Unknown status NCT01959568
43 Effectiveness of Therapeutic Treatment: Hot and Cold Self-regulation in Posttraumatic Stress Disorder, Dissociative Disorder, and Borderline Personality Disorder Completed NCT02459340
44 Macular Detachment Associated With Intrachoroidal Cavitation Completed NCT01959724
45 Prevalence of Dissociative Disorders in Children in a Population Supported in the Medico-social and Health Structures in Provence Alpes Cote d'Azur Completed NCT01512641
46 EXPLORATION OF THE SOCIAL COGNITION IN ADOLESCENTS WITH A Dissociative Disorder OR AUTISM SPECTRUM Completed NCT01805128
47 Primary Vitrectomy Combined With 360° Endolaser or Encircling Band for Rhegmatogenous Retinal Detachment (V.E.E. Study) Completed NCT00757536
48 Proinflammatory Cytokine Levels in Patients With Conversion Disorder Completed NCT00971360
49 Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy But Without Optic Disc Pit Nor High Myopia Completed NCT01862627
50 Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies Completed NCT00408720

Search NIH Clinical Center for Dissociative Disorder

Cochrane evidence based reviews: dissociative disorders

Genetic Tests for Dissociative Disorder

Anatomical Context for Dissociative Disorder

MalaCards organs/tissues related to Dissociative Disorder:

40
Eye, Endothelial, Brain, Cortex, Retina, Prefrontal Cortex, Testes

Publications for Dissociative Disorder

Articles related to Dissociative Disorder:

(show top 50) (show all 393)
# Title Authors PMID Year
1
Dissociative symptoms as measured by the Cambridge Depersonalization Scale in patients with a bipolar disorder. 61
31818776 2020
2
Difficulty differentiating a case of posterior cortical atrophy from a psychogenic disturbance of vision. 61
30997705 2020
3
A Patient's View of the Challenges and Blessings of Her Dissociative Disorder. 61
31852054 2020
4
Association between affective disorders presenting before and during pregnancy and pre-term birth, considering socio-demographic factors, obstetric factors, health conditions, and use of medication. 61
30454957 2019
5
Investigating the prevalence of dissociative disorders and severe dissociative symptoms in first episode psychosis. 61
30585427 2019
6
Pharmacotherapy for dissociative disorders: A systematic review. 61
31470213 2019
7
Rapid carbene formation increases ion diffusivity in an imidazolium acetate ionic liquid confined between polar glass plates. 61
31588443 2019
8
Post-Dissociative Trance Disorder: Traditional Culture of Nini Pagar from Tigabinanga. 61
31777635 2019
9
Low high-density lipoprotein and psychopathology: A review. 61
31369659 2019
10
Kuda Kepang: A Case Report of Javanese Cultural-Related Trance in Medan. 61
31777641 2019
11
Functional Connectivity Between Extrastriate Body Area and Default Mode Network Predicts Depersonalization Symptoms in Major Depression: Findings From an A Priori Specified Multinetwork Comparison. 61
31103548 2019
12
Can the Trauma Symptom Inventory-2 distinguish coached simulators from dissociative disorder patients? 61
30024218 2019
13
The 6-D Model of National Culture as a Tool to Examine Cultural Interpretation of Migration Trauma-Related Dissociative Disorder: A Case Series. 61
31165366 2019
14
[Sleep related dissociative disorder: A case complicated by a suicide attempt]. 61
29983174 2019
15
Hospital Admission for Severe Pediatric Dissociative Disorder. 61
30925508 2019
16
Neuro-Cognition in Adolescents with Dissociative Disorder: A Study from a Tertiary Care Center of North India. 61
31142926 2019
17
Perceived parental style, cognitive style, and resilience in females with dissociative disorder in India. 61
30992613 2019
18
Preliminary Evidence of a Missing Self Bias in Face Perception for Individuals with Dissociative Identity Disorder. 61
30445887 2019
19
Epidemiology of mental disorders during pregnancy and link to birth outcome: a large-scale retrospective observational database study including 38,000 pregnancies. 61
30734864 2019
20
Night Stepping: Fitbit Cracks the Case. 61
30736884 2019
21
Reconsidering the autohypnotic model of the dissociative disorders. 61
29565750 2019
22
Psychoform and somatoform dissociative experiences in migraine: relationship with pain perception and migraine related disability. 61
30604937 2018
23
Psychometric properties of the pathological dissociation measures among Chinese - a pilot study using online methods. 61
29589801 2018
24
Dissociative adsorption of a multifunctional compound on a semiconductor surface: a theoretical study of the adsorption of hydroxylamine on Ge(100). 61
29796455 2018
25
Violent Parasomnia With Recurrent Biting and Surgical Interventions: Case Report and Differential Diagnosis. 61
29734991 2018
26
Disconnected - Impaired Interoceptive Accuracy and Its Association With Self-Perception and Cardiac Vagal Tone in Patients With Dissociative Disorder. 61
29997537 2018
27
Psychological Dissection of Patients Having Dissociative Disorder: A Cross-sectional Study. 61
29403129 2018
28
The enemy in the mirror: self-perception-induced stress results in dissociation of psychological and physiological responses in patients with dissociative disorder. 61
29938011 2018
29
Trauma-related altered states of consciousness in post-traumatic stress disorder patients with or without comorbid dissociative disorders. 61
30455853 2018
30
Engendered Responses to, and Interventions for, Shame in Dissociative Disorders: A Survey and Experimental Investigation. 61
28915146 2017
31
Acute dissociative reaction to spontaneous delivery in a case of total denial of pregnancy: Diagnostic and forensic aspects. 61
27997287 2017
32
Transition State Analysis of Adenosine Triphosphate Phosphoribosyltransferase. 61
28872824 2017
33
Partial mediator role of physical abuse on the relationship between attention-deficit/hyperactivity disorder symptoms and severity of dissociative experiences in a sample of inpatients with alcohol use disorder. 61
29085089 2017
34
Somatoform dissociation and posttraumatic stress syndrome - two sides of the same medal? A comparison of symptom profiles, trauma history and altered affect regulation between patients with functional neurological symptoms and patients with PTSD. 61
28693577 2017
35
Dissociation: Defining the Concept in Criminal Forensic Psychiatry. 61
28619854 2017
36
Exploring the full catalytic cycle of rhodium(i)-BINAP-catalysed isomerisation of allylic amines: a graph theory approach for path optimisation. 61
28970877 2017
37
Stereotypy of psychogenic nonepileptic seizures. 61
28427022 2017
38
Issues in consultation for treatments with distressed activated abuser/protector self-states in dissociative identity disorder. 61
28277976 2017
39
Predicting a dissociative disorder from type of childhood maltreatment and abuser-abused relational tie. 61
28318411 2017
40
Dissociative disorders in acute psychiatric inpatients in Taiwan. 61
28189923 2017
41
Trauma-related dissociation: Psychological features and psychophysiological responses to script-driven imagery in borderline personality disorder. 61
27914166 2017
42
Is there a complex relation between social anxiety disorder, childhood traumatic experiences and dissociation? 61
27564540 2017
43
Is high hypnotizability a necessary diathesis for pathological dissociation? 61
27216366 2017
44
Treatment of dissociative disorders and reported changes in inpatient and outpatient cost estimates. 61
29038681 2017
45
Assessment of complex dissociative disorder patients and simulated dissociation in forensic contexts. 61
28029435 2016
46
A study of phenomenology, psychiatric co-morbidities, social and adaptive functioning in children and adolescents with OCD. 61
27520897 2016
47
Incidence of posterior reversible encephalopathy syndrome in eclamptic and patients with preeclampsia with neurologic symptoms. 61
26902987 2016
48
Adult with Middle Interhemispheric Variant of Holoprosencephaly: Neuropsychological, Clinical, and Radiological Findings. 61
27235161 2016
49
Tracking down the footprints of bad paternal relationships in dissociative disorders: A diffusion tensor imaging study. 61
26566870 2016
50
Relationship of cognitive function and adjustment difficulties among children and adolescents with dissociative disorder. 61
27114655 2016

Variations for Dissociative Disorder

Expression for Dissociative Disorder

Search GEO for disease gene expression data for Dissociative Disorder.

Pathways for Dissociative Disorder

Pathways related to Dissociative Disorder according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.07 SLC6A4 HTR2A

GO Terms for Dissociative Disorder

Cellular components related to Dissociative Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cortical cytoskeleton GO:0030863 8.62 FLNA DMTN

Biological processes related to Dissociative Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 female pregnancy GO:0007565 9.5 SLC38A3 OXT NPPA
2 memory GO:0007613 9.33 SLC6A4 OXT HTR2A
3 sleep GO:0030431 9.26 OXT HTR2A
4 positive regulation of integrin-mediated signaling pathway GO:2001046 8.96 FLNA DMTN
5 sperm ejaculation GO:0042713 8.62 SLC6A4 OXT

Molecular functions related to Dissociative Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuropeptide hormone activity GO:0005184 8.96 OXT NPPA
2 serotonin binding GO:0051378 8.62 SLC6A4 HTR2A

Sources for Dissociative Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....